Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
04/21/2010 | CN101695573A Method for producing pseudorabies living vaccines by using subculture cell source and product thereof |
04/21/2010 | CN101695572A Method for producing pseudorabies attenuated vaccine by using bioreactor and pseudorabies attenuated vaccine product |
04/21/2010 | CN101695571A Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product |
04/21/2010 | CN101695570A Univalent and bivalent inactivated vaccine for hand-foot-and-mouth disease and preparation method thereof |
04/21/2010 | CN101695569A Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof |
04/20/2010 | US7700350 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion |
04/20/2010 | US7700342 Lentiviral packaging constructs |
04/20/2010 | US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane |
04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
04/20/2010 | US7700103 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
04/15/2010 | US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera |
04/15/2010 | US20100093059 Method for the Preparation of Sulfated Cellulose Membranes and Sulfated Cellulose Membranes |
04/15/2010 | US20100093058 High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type |
04/15/2010 | US20100092515 Herpes simplex viruses and methods of viral replication |
04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
04/15/2010 | US20100092510 Turkey herpesvirus vectored recombinant containing avian influenza genes |
04/15/2010 | US20100092508 Molecular Antigen Arrays |
04/15/2010 | US20100092502 Modified hiv env polypeptides |
04/15/2010 | US20100092431 Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
04/15/2010 | US20100092430 Attenuated oncolytic paramyxoviruses encoding avian cytokines |
04/14/2010 | EP2173866A2 Vaccine production for pathogenic bird viral diseases |
04/14/2010 | EP2173865A2 Apparatus and method for harvesting biologics from eggs |
04/14/2010 | EP1797174B1 Method for preparing viral material |
04/14/2010 | EP1002055B2 Recovery of virus from cell culture using a hypertonic salt solution |
04/14/2010 | CN101694832A Method and combination for making multi-length thin film |
04/14/2010 | CN101693894A Avian influenza virus H5N1 pseudotype virus, process for preparation and special DNA fragment thereof |
04/14/2010 | CN101693887A Fast cultivation and identification method of high throughput virus and applications thereof |
04/14/2010 | CN101693672A Peptidomimetic protease inhibitors |
04/13/2010 | US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
04/13/2010 | US7695724 Recombinant rabies virus compositions |
04/13/2010 | CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
04/13/2010 | CA2244946C Gene expression vectors which generate an antigen specific immune response and methods of using the same |
04/13/2010 | CA2232264C Variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) with increased thermal stability |
04/08/2010 | WO2010039056A1 Method for producing a nucleoprotein nanoparticle |
04/08/2010 | WO2010038719A1 Method for producing purified influenza virus antigen |
04/08/2010 | WO2010037403A1 Hepatitis c virus expressing reporter tagged ns5a protein |
04/08/2010 | US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
04/08/2010 | US20100087382 Inhibitors of Hepatitis C NS3 Protease |
04/08/2010 | US20100086565 Vectors for expression of hml-2 polypeptides |
04/08/2010 | US20100086564 West Nile Virus Vaccine |
04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
04/07/2010 | EP2172543A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
04/07/2010 | EP2172227A1 Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby |
04/07/2010 | EP2171046A2 Bacteriophage with enhanced lytic activity |
04/07/2010 | EP2170935A2 Hpiv-2 variants and medical applications thereof |
04/07/2010 | EP2170933A1 Novel plant virus designated tomato marchitez virus |
04/07/2010 | EP2170382A1 An attenuated influenza virus and a live vaccine comprising the same |
04/07/2010 | EP1907536B1 Cell line for producing coronaviruses |
04/07/2010 | EP1723168B1 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
04/07/2010 | CN101690808A Method for preparing swine fever-pseudorabies bigeminal live vaccine and product thereof |
04/06/2010 | US7691627 Nucleic acid sequences encoding D1 and D1/D2 domains of human coxsackievirus and adenovirus receptor (CAR) |
04/06/2010 | US7691386 comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; drug delivery |
04/06/2010 | CA2617830C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
04/06/2010 | CA2303477C Chimaeric adenoviruses |
04/06/2010 | CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
04/01/2010 | WO2010036774A1 Methods for purification of viruses |
04/01/2010 | WO2010036760A1 Methods for cultivating cells, propagating and purifying viruses |
04/01/2010 | US20100080825 Filovirus vectors and noninfectious filovirus-based particles |
04/01/2010 | US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies |
04/01/2010 | US20100080775 Recombinant adenoviruses encoding the specific iodine transporter (nis) |
04/01/2010 | CA2738024A1 Methods for purification of viruses |
04/01/2010 | CA2738022A1 Methods for cultivating cells, propagating and purifying viruses |
03/31/2010 | EP2169073A1 Vector for the preparation of immunotherapeutical compositions |
03/31/2010 | EP1278878B1 Codon optimized eiav vectors |
03/31/2010 | CN101688197A Hcv gene |
03/31/2010 | CN101688188A Method for purifying a viral suspension |
03/31/2010 | CN101688187A Formulation of sugar solutions for continuous ultracentrifugation for virus purification |
03/31/2010 | CN101688186A Two-step temperature profile for the propagation of viruses |
03/31/2010 | CN101688185A Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection |
03/31/2010 | CN101688184A recombinant rhinovirus vectors |
03/31/2010 | CN101688182A Immortalized avian cell lines |
03/31/2010 | CN101684477A Novel tumor target gene therapy system based on gland virus replication and recombination |
03/31/2010 | CN101683523A Preparation method of prostatic cancer specific DC cell vaccine which is insensitive to TGF-belta |
03/30/2010 | US7687611 Assay for the separation and quantification of hemagglutinin antigens |
03/30/2010 | US7687240 Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV |
03/25/2010 | WO2010033486A1 Vaccines containing canine parvovirus genetic variants |
03/25/2010 | WO2010031837A1 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
03/25/2010 | WO2010031783A1 Mutant pestivirus with mutations in core gene and ns3 region |
03/25/2010 | WO2009136382A3 Antibodies to receptor of advanced glycation end products (rage) and uses thereof |
03/25/2010 | US20100075399 Methods for protein refolding |
03/25/2010 | US20100075398 Bacteriophage Preparations and Method of Use Thereof |
03/25/2010 | US20100075301 Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface |
03/25/2010 | US20100075299 Detection and use of antiviral resistance mutations |
03/25/2010 | US20100074889 4'-allene-substituted nucleoside derivatives |
03/25/2010 | US20100074869 Multifunctional Cytokines |
03/25/2010 | CA2737378A1 Vaccines containing canine parvovirus genetic variants |
03/24/2010 | EP2166107A1 Lentiviral vectors for the expression of shRNA |
03/24/2010 | EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease |
03/24/2010 | CN101679954A Methods and compositions for live attenuated viruses |
03/24/2010 | CN101679953A Mutant reoviruses and methods of making and using |
03/24/2010 | CN101676389A Modified vaccinia ankara virus variant |
03/24/2010 | CN101676388A Avian cell lines for the production of useful substances |
03/23/2010 | US7682618 Generation of virus-like particles and use as panfilovirus vaccine |
03/23/2010 | CA2225388C Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
03/18/2010 | WO2009138752A3 Fish vaccine |
03/18/2010 | US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein |
03/18/2010 | US20100068787 Novel Staphylococcus aureus: Bacteriophage and Uses Thereof |